Therapix Biosciences launches its IPO on NASDAQ on Wednesday, March 22, under the trading symbol TRPX. The Tel Aviv-based company specializing in the development and commercialization of cannabinoid-based treatments has a drug for Tourette Syndrome in Phase 2a trials and is additionally developing a drug for mild cognitive impairment. The IPO helps put it on […]

by

Recent studies concerning the therapeutic attributes of Cannabidiol (CBD) have pointed to growing evidence to suggest that it could help in the treatment of anxiety-related and other health disorders. With recent research and development aimed at identifying new therapies and treatments for various ailments, companies are focusing on improving therapies such as: India Globalization Capital, Inc. […]

by

Cara Therapeutics Inc. (NASDAQ: CARA) showing jumped of 5.89% and closed at $16.17, after gaining total volume of 1.37 million shares. Its earnings per share (EPS) is -$2.10 and its beta value stands at 3.20 points and has total market capitalization of $430.77 million and a total of 27.30 million outstanding shares. Cara Therapeutics Inc. […]

by

Recent studies concerning the therapeutic attributes of Cannabidiol (CBD) have pointed to growing evidence to suggest that it could help in the treatment of anxiety-related and other health disorders. With recent research and development aimed at identifying new therapies and treatments for various ailments, companies are focusing on improving therapies such as: India Globalization Capital, Inc. […]

by

He believes much of the misinformation is spread on social media. “Some people believe that when you are talking about medicinal cannabis, it is the same as taking the drugs recreationally. “Some people think you can smoke joints to help epilepsy.” It is entirely understandable that patients with some conditions try some of the oils […]

by

He believes much of the misinformation is spread on social media. “Some people believe that when you are talking about medicinal cannabis, it is the same as taking the drugs recreationally. “Some people think you can smoke joints to help epilepsy.” It is entirely understandable that patients with some conditions try some of the oils […]

by

LONDON, March 07, 2017 — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced the appointment of Scott Giacobello as Chief Financial Officer on 6 March 2017. Reporting to GW’s Chief Executive Officer Justin Gover, […]

by

The cannabis industry has swiftly turned into a multi-billion dollar opportunity. In the United States, this market’s massive growth potential is being recognized as new states legalize marijuana for medical or recreational use. Industry experts forecast the U.S. cannabis market rounding $7 billion in 2016, while the annual sale of state-legal cannabis products is forecast […]

by

LONDON, March 07, 2017 — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced the appointment of Scott Giacobello as Chief Financial Officer on 6 March 2017. Reporting to GW’s Chief Executive Officer Justin Gover, […]

by

Whenever Jessie Opoien | The Capital Times posts new content, you’ll get an email delivered to your inbox with a link. Email notifications are only sent once a day, and only if there are new matching items. … read more at: http://host.madison.com/ct/news/local/govt-and-politics/election-matters/wisconsin-democrats-introduce-bills-aimed-at-legalizing-medical-marijuana/article_e96d56c7-5fb0-50b5-917e-97421493f37e.html

by